Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 4/2019

01-08-2019 | Stroke | Research Article

Characteristic of drug-related problems and pharmacists’ interventions in a stroke unit in Thailand

Authors: Kannikar Semcharoen, Sajja Supornpun, Surakit Nathisuwan, Junporn Kongwatcharapong

Published in: International Journal of Clinical Pharmacy | Issue 4/2019

Login to get access

Abstract

Background Little information is available regarding pharmacist’s intervention to solve drug-related problems (DRPs) in a stroke unit. Objective To investigate the nature and frequency of DRPs along with the role of pharmacists in a stroke unit. Setting The study was conducted at the stroke unit of Siriraj hospital, a university affiliated tertiary care hospital in Thailand. Method A retrospective descriptive study of DRPs and pharmacists’ interventions for stroke patients was performed during July 2015 to December 2016. Data were collected from patient’s medical records and pharmacist’s intervention record forms. DRPs were categorized using the Hepler–Strand classification. The stroke pharmacist team, consisting of a board-certified pharmacotherapy specialist, neurology pharmacy residents and stroke unit pharmacists, participated in the multidisciplinary ward round in the stroke unit 5 days a week. All patients were visited by a member of the stroke pharmacist team within the first two days of their admission to conduct a thorough review of drug therapy for every patient and provided appropriate recommendation to the multidisciplinary team either verbally during the ward round or with written information in the patients’ medical charts, as appropriate. Main Outcome Measure (a) incidence and characteristics of DRPs (b) types and the acceptance of pharmacists’ interventions. Results A total of 859 patients were admitted, of those, 768 patients had ≥ 1 DRPs and a total of 796 DRPs were identified. Clinical pharmacists provided 659 interventions to the multidisciplinary team. The most common DRPs identified were “untreated indications” (22.6%) and “non-compliance” (21.0%). Of all DRPs, 74.6% were stroke related issues. The most implicated drugs were antihypertensive drugs, followed by antithrombotic therapies. The multidisciplinary team accepted 84.7% of pharmacists’ interventions. Conclusion DRP in a stroke unit is common. Clinical pharmacists in a stroke unit can effectively reduce and prevent DRPs with the focus on performing medication reconciliation, providing recommendation on dosage adjustment and proper drug selection for stroke patients.
Literature
1.
go back to reference Institute of Medicine Committee on Quality of Health Care in America. Errors in health care: a leading cause of death and injury. In: Kohn LT, Corrigan JM, Donaldson MS, editors. To err is human: building a safer health system. Washington, DC: National Academies Press; 2000. p. 26–48. Institute of Medicine Committee on Quality of Health Care in America. Errors in health care: a leading cause of death and injury. In: Kohn LT, Corrigan JM, Donaldson MS, editors. To err is human: building a safer health system. Washington, DC: National Academies Press; 2000. p. 26–48.
2.
go back to reference Miguel A, Azevedo LF, Araujo M, Pereira AC. Frequency of adverse drug reactions in hospitalized patients: a systematic review and meta-analysis. Pharmacoepidemiol Drug Saf. 2012;21(11):1139–54.CrossRefPubMed Miguel A, Azevedo LF, Araujo M, Pereira AC. Frequency of adverse drug reactions in hospitalized patients: a systematic review and meta-analysis. Pharmacoepidemiol Drug Saf. 2012;21(11):1139–54.CrossRefPubMed
3.
go back to reference de Vries EN, Ramrattan MA, Smorenburg SM, Gouma DJ, Boermeester MA. The incidence and nature of in-hospital adverse events: a systematic review. Qual Saf Health Care. 2008;17(3):216–23.CrossRefPubMedPubMedCentral de Vries EN, Ramrattan MA, Smorenburg SM, Gouma DJ, Boermeester MA. The incidence and nature of in-hospital adverse events: a systematic review. Qual Saf Health Care. 2008;17(3):216–23.CrossRefPubMedPubMedCentral
4.
go back to reference Bates DW, Spell N, Cullen DJ, Burdick E, Laird N, Petersen LA. The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group. J Am Med Assoc. 1997;277(4):307–11.CrossRef Bates DW, Spell N, Cullen DJ, Burdick E, Laird N, Petersen LA. The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group. J Am Med Assoc. 1997;277(4):307–11.CrossRef
5.
go back to reference Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47(3):533–43.PubMed Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47(3):533–43.PubMed
6.
go back to reference Leape LL, Cullen DJ, Clapp MD, Burdick E, Demonaco HJ, Erickson JI, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. J Am Med Assoc. 1999;282(3):267–70.CrossRef Leape LL, Cullen DJ, Clapp MD, Burdick E, Demonaco HJ, Erickson JI, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. J Am Med Assoc. 1999;282(3):267–70.CrossRef
7.
go back to reference Kaboli PJ, Hoth AB, McClimon BJ, Schnipper JL. Clinical pharmacists and inpatient medical care: a systematic review. Arch Intern Med. 2006;166(9):955–64.CrossRefPubMed Kaboli PJ, Hoth AB, McClimon BJ, Schnipper JL. Clinical pharmacists and inpatient medical care: a systematic review. Arch Intern Med. 2006;166(9):955–64.CrossRefPubMed
8.
go back to reference Kucukarslan SN, Peters M, Mlynarek M, Nafziger DA. Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units. Arch Intern Med. 2003;163(17):2014–8.CrossRefPubMed Kucukarslan SN, Peters M, Mlynarek M, Nafziger DA. Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units. Arch Intern Med. 2003;163(17):2014–8.CrossRefPubMed
9.
go back to reference Dooley MJ, Allen KM, Doecke CJ, Galbraith KJ, Taylor GR, Bright J, et al. A prospective multicentre study of pharmacist initiated changes to drug therapy and patient management in acute care government funded hospitals. Br J Clin Pharmacol. 2004;57(4):513–21.CrossRefPubMedPubMedCentral Dooley MJ, Allen KM, Doecke CJ, Galbraith KJ, Taylor GR, Bright J, et al. A prospective multicentre study of pharmacist initiated changes to drug therapy and patient management in acute care government funded hospitals. Br J Clin Pharmacol. 2004;57(4):513–21.CrossRefPubMedPubMedCentral
10.
go back to reference Sagita VA, Bahtiar A, Andrajati R. Evaluation of a clinical pharmacist intervention on clinical and drug-related problems among coronary heart disease inpatients: a pre-experimental prospective study at a general hospital in Indonesia. Sultan Qaboos Univ Med J. 2018;18(1):e81–7.CrossRefPubMedPubMedCentral Sagita VA, Bahtiar A, Andrajati R. Evaluation of a clinical pharmacist intervention on clinical and drug-related problems among coronary heart disease inpatients: a pre-experimental prospective study at a general hospital in Indonesia. Sultan Qaboos Univ Med J. 2018;18(1):e81–7.CrossRefPubMedPubMedCentral
11.
go back to reference Hanlon JT, Semla TP, Schmader KE. Alternative Medications for medications in the use of high-risk medications in the elderly and potentially harmful drug-disease interactions in the elderly quality measures. J Am Geriatr Soc. 2015;63(12):1–11.CrossRef Hanlon JT, Semla TP, Schmader KE. Alternative Medications for medications in the use of high-risk medications in the elderly and potentially harmful drug-disease interactions in the elderly quality measures. J Am Geriatr Soc. 2015;63(12):1–11.CrossRef
12.
go back to reference Kanagala VS, Anusha A, Rao BS, Challa SR, Nalla KS, Gadde RS. A study of medication-related problems in stroke patients: a need for pharmaceutical care. J Res Pharm Pract. 2016;5(3):222–5.CrossRefPubMedPubMedCentral Kanagala VS, Anusha A, Rao BS, Challa SR, Nalla KS, Gadde RS. A study of medication-related problems in stroke patients: a need for pharmaceutical care. J Res Pharm Pract. 2016;5(3):222–5.CrossRefPubMedPubMedCentral
13.
go back to reference Celin A, Seuma J, Ramesh A. Assessment of drug related problems in stroke patients admitted to a South Indian tertiary care teaching hospital. Indian J Pharm Pract. 2012;5(4):28–33. Celin A, Seuma J, Ramesh A. Assessment of drug related problems in stroke patients admitted to a South Indian tertiary care teaching hospital. Indian J Pharm Pract. 2012;5(4):28–33.
14.
go back to reference Hohmann C, Neumann-Haefelin T, Klotz JM, Freidank A, Radziwill R. Drug-related problems in patients with ischemic stroke in hospital. Int J Clin Pharm. 2012;34(6):828–31.CrossRefPubMed Hohmann C, Neumann-Haefelin T, Klotz JM, Freidank A, Radziwill R. Drug-related problems in patients with ischemic stroke in hospital. Int J Clin Pharm. 2012;34(6):828–31.CrossRefPubMed
15.
go back to reference Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. 2018 Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2018;49(3):e46–110.CrossRef Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. 2018 Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2018;49(3):e46–110.CrossRef
16.
go back to reference Daniel WW, Cross CL. Biostatistics: a foundation for analysis in the health sciences. Hoboken: Wiley; 2013. ISBN: 978-1-118-30279-8. Daniel WW, Cross CL. Biostatistics: a foundation for analysis in the health sciences. Hoboken: Wiley; 2013. ISBN: 978-1-118-30279-8.
17.
go back to reference Allenet B, Bedouch P, Rose FX, Escofier L, Roubille R, Charpiat B. Validation of an instrument for the documentation of clinical pharmacists’ interventions. Pharm World Sci. 2006;28(4):181–8.CrossRefPubMed Allenet B, Bedouch P, Rose FX, Escofier L, Roubille R, Charpiat B. Validation of an instrument for the documentation of clinical pharmacists’ interventions. Pharm World Sci. 2006;28(4):181–8.CrossRefPubMed
18.
Metadata
Title
Characteristic of drug-related problems and pharmacists’ interventions in a stroke unit in Thailand
Authors
Kannikar Semcharoen
Sajja Supornpun
Surakit Nathisuwan
Junporn Kongwatcharapong
Publication date
01-08-2019
Publisher
Springer International Publishing
Published in
International Journal of Clinical Pharmacy / Issue 4/2019
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-019-00832-4

Other articles of this Issue 4/2019

International Journal of Clinical Pharmacy 4/2019 Go to the issue